Posts

Mid-Year Healthcare Venture Trends to Watch in 2026

on

Spotlight On: Five Healthtech Investor Trends Pharma Should Watch

on

The Oncology Market: Outlook for 2026

on

Shaping What's Next in Drug Delivery: 2026 Trends and Innovations

on

Inside the Race to Build the Next Generation of AI Drug Discovery Platforms

on

Biotech's Groove is Back for 2026: XBI Surges Amid M&A Boom and Lower Rates

on

Health tech investors are getting creative with exits in 2025

on

Navigating JPM 2026: Biotech/Biopharma Trends, Policy Impacts, and Forward Outlook

on

From JP Morgan to the Next Wave: What’s Driving Biotech in 2026

on

FDA Drug Approvals in 2025 Remain Within Recent Averages Amid Agency Upheaval

on

Endpoints News Launches Industry Sentiment Survey, But No Evidence Yet of a New Biopharma Sentiment Index

on

Endpoints News to Announce 2025 'Endpoints 11' Biotechs to Watch Live in Boston

on

How Past Endpoints 11 Winners Fared During the 2025 Biotech Downturn

on

Recent Developments in Building Measurable Patient Support Programs (2025)

on

Biopharma Layoffs Continue to Surge in First Half of 2025

on

Beyond Theory: Real-World AI Wins in Life Science R&D – Faster & Smarter

on

Exit Strategy: Biopharma Professionals Consider Opportunities Outside Industry and US

on

Sanofi Commits $20 Billion to US Expansion Amid Industry-Wide Investment Surge

on

AI Drug Discovery Firm Insitro Lays Off 22% of Workforce Amid Ongoing Biotech Market Turmoil

on

Navigating the Biotech Winter: Strategies for Survival and Growth Amid Ongoing Industry Downturn

on